TSHA Chart
See on advanced chart >
About
Taysha Gene Therapies, Inc. was originally formed under the laws of the State of Texas on September 20, 2019. The company converted to a Delaware corporation on February 13, 2020.The company is a patient-centric gene therapy company focused on developing and...
Read More
- HighlightA pivotal-stage gene therapy company that develops AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system
- ExchangeNASDAQ
- Listing Date09/24/2020
- Established Date09/20/2019
- Full-time Employees65
- Address3000 Pegasus Park Dr. Ste 1430 Dallas Texas 75247
- Tel1-214-6120000
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology
